◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Max Financial Services Limited (MFSL) Revenue 2023–TTM

Name: Max Financial Services Limited (MFSL) revenue history 2023-TTM
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-10-22

Max Financial Services Limited annual revenue for fiscal TTM was ₹498.2 billion, an increase of 4.7% from ₹475.9 billion in fiscal 2026. All figures are reported results from public filings — no estimates or projections.

MFSL Annual Revenue

Revenue (annual)	TTM → 2026-06-30	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹498.2B	₹475.9B	₹464.0B	₹464.9B	₹313.3B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MFSL Quarterly Revenue

Revenue (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Total Revenue	₹149.7B	₹108.0B	₹142.6B	₹97.9B	₹128.2B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Revenue at Comparable Companies

1299 Revenue — AIA Group Limited
2628 Revenue — China Life Insurance Company Limited
ICICIPRULI Revenue — ICICI Life Insurance Ltd
0945 Revenue — Manulife Financial Corporation
STARHEALTH Revenue — Star Health and Allied Insurance Company Limited
2601 Revenue — China Pacific Insurance (Group) Co., Ltd.

More MFSL metrics: Net Income · EPS · Free Cash Flow

All MFSL financial statements → Interactive MFSL charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.